Related Experiment Video
Updated: May 2, 2026

09:41
Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
Published on: March 5, 2020
9.1K
Macro- and microscale variables regulate stent haemodynamics, fibrin deposition and thrombomodulin expression
Juan M Jiménez1, Varesh Prasad, Michael D Yu
1Department of Pathology and Laboratory Medicine, University of Pennsylvania, , Philadelphia, PA 19104, USA.
Journal of the Royal Society, Interface
|February 21, 2014
Summary
Drug eluting stents can cause late stent thrombosis. Thinner, streamlined stent designs reduce blood clot formation and improve healing by minimizing harmful flow patterns and enhancing anticoagulant properties.
Area of Science:
- Biomedical Engineering
- Cardiovascular Research
- Fluid Dynamics
Background:
- Drug-eluting stents (DES) are linked to late stent thrombosis (LST) and delayed healing.
- Stent strut exposure to blood flow can initiate prothrombotic conditions.
Purpose of the Study:
- To investigate how microscale stent strut geometry affects prothrombotic conditions under various fluid flow conditions.
- To determine the impact of strut design on fibrin deposition and endothelial thrombomodulin (TM) expression.
Main Methods:
- Numerical simulations of fluid flow dynamics around different stent strut geometries.
- Experimental particle flow visualization to observe recirculation zones and fibrin deposition.
- Assessment of endothelial thrombomodulin (TM) expression in relation to strut design.
Main Results:
- Stent strut geometry and bulk fluid flow interact to regulate peristrut flow recirculation zones.
- Thinner and streamlined strut designs significantly reduced recirculation zones and fibrin deposition.
- Reduced recirculation correlated with increased endothelial anticoagulant TM expression.
Conclusions:
- Microscale strut geometry is a critical factor in stent thrombogenicity.
- Optimizing stent strut design (thinner, streamlined) can mitigate LST risk and improve healing.
- Findings provide insights into physical and functional consequences influencing current stent designs and LST.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Clot Retraction and Fibrinolysis
6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
![Development and Characterization of In Vitro Microvessel Network and Quantitative Measurements of Endothelial [Ca2+]i and Nitric Oxide Production](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F54014.jpg&w=3840&q=50)
